Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by Noteableon May 23, 2023 6:41pm

220 Views

Post# 35461004

ONCY afterhour trades

After Hours: $1.94 0.15 | 8.38%May 23, 2023 6:20 PMEDTVolume: 16,005

After Hours Time (ET)	After Hours Price	After Hours Share Volume
18:20:14	$1.94	5
18:17:48	$1.92	4,921
18:15:17	$1.88	79
17:56:15	$1.88	9,500
17:54:16	$1.85	500
17:10:43	$1.84	150
17:10:43	$1.84	50
16:45:37	$1.84	100
16:45:37	$1.84	100
16:45:17	$1.84	200
16:44:34	$1.84	300
16:44:34	$1.84	100